Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Healthtrust
US Department of Justice
Farmers Insurance
Argus Health
McKesson
Boehringer Ingelheim
Moodys
Express Scripts
Merck

Generated: February 22, 2018

DrugPatentWatch Database Preview

SECOBARBITAL SODIUM Drug Profile

« Back to Dashboard

When do Secobarbital Sodium patents expire, and when can generic versions of Secobarbital Sodium launch?

Secobarbital Sodium is a drug marketed by Anabolic, Barr, Everylife, Halsey, Ivax Pharms, Kv Pharm, Lannett, Parke Davis, Perrigo, Purepac Pharm, Valeant Pharm Intl, Vitarine, Watson Labs, West Ward, Whiteworth Town Plsn, Wyeth Ayerst, and Elkins Sinn. and is included in twenty NDAs.

The generic ingredient in SECOBARBITAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the secobarbital sodium profile page.
Drug patent expirations by year for SECOBARBITAL SODIUM
Medical Subject Heading (MeSH) Categories for SECOBARBITAL SODIUM

US Patents and Regulatory Information for SECOBARBITAL SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anabolic SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 084422-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 086390-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 085909-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Halsey SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 084676-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharm Intl SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 085477-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst SECOBARBITAL SODIUM secobarbital sodium INJECTABLE;INJECTION 083262-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 085903-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Elkins Sinn SECOBARBITAL SODIUM secobarbital sodium INJECTABLE;INJECTION 083281-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West Ward SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 084926-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Vitarine SECOBARBITAL SODIUM secobarbital sodium CAPSULE;ORAL 086273-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
Express Scripts
Baxter
McKinsey
AstraZeneca
Chubb
Chinese Patent Office
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot